VEGFA and colorectal cancer: In addition, pre-clinical data from numerous other studies have also reported that γ-T3 alleviates angiogenic protein expression (VEGF) in colorectal cancer [88], malignant mesothelioma [89], breast cancer [90], ovarian carcinoma [91], head and neck squamous cell carcinomas [92], and other cancers.